CARCINOMA, NON-SMALL-CELL LUNG

This UK trial is testing whether two already-approved cancer drugs, dabrafenib and trametinib, can effectively treat rare cancers or common cancers with a rare genetic change called a BRAF V600 mutation. The study will enroll about 30 adults and children with various cancers that…

This study is testing an experimental medicine called N17350, which is injected directly into tumors of adults with advanced solid cancers that have spread or stopped responding to standard treatments. The main goals are to find the safest and most effective dose, check for side …

This study is testing if adding an inhaled drug called azacytidine to standard pre-surgery treatment can better fight early-stage lung cancer. The inhaled drug is designed to target the lungs directly with fewer side effects. About 60 adults with operable lung cancer will receive…

This study compares two types of lung cancer surgery for patients who have already responded well to immunotherapy. It aims to see if a less extensive surgery, which removes less lung tissue, is as effective at controlling cancer as the standard, more extensive surgery. The goal …

This study is testing a new way to plan radiation therapy for lung cancer. Researchers will use a special type of MRI scan that uses xenon gas to create a detailed 3D map of how well different parts of the lungs are working. The goal is to direct the radiation beams more precisel…

This study aims to see if a new drug called QL2107 behaves the same way in the body as the established cancer drug Keytruda. It will involve 122 adults with non-small cell lung cancer who have had their tumor surgically removed and completed chemotherapy. The main goal is to prov…